CRSP - CRISPR Therapeutics AG
60
1.940 3.233%
Share volume: 1,170,589
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$58.06
1.94
0.03%
Summary score
5%
Profitability
0%
Dept financing
5%
Liquidity
50%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-6.27%
Return on assets
-5.44%
Return on sales
0%
Return on invested capital
-214.13%
Total debt ratio
23.04%
Debt ratio change over timeo
0%
Current Ratio
16.51%
Quick Ratio
0%
Cash Position Ratio
15.74%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-5.06%
Return on assets
-5.05%
Return on sales
0%
Return on invested capital
-603.25%
Total debt ratio
11.62%
Debt ratio change over timeo
0%
Current Ratio
15.8%
Quick Ratio
0%
Cash Position Ratio
14.43%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-6.88%
Return on assets
-6.22%
Return on sales
0%
Return on invested capital
-930.91%
Total debt ratio
9.54%
Debt ratio change over time
0%
Current Ratio
16.53%
Quick Ratio
0%
Cash Position Ratio
12.38%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CRSP | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -6.27% | 12.3% | 4.66% | 8.41% |
| Return on assets | -5.44% | 3.6% | 3.82% | 5.9% |
| Return on sales | 0% | 41.82% | 38.61% | 44.98% |
| Return on invested capital | -214.13% | 7.81% | 4.85% | 8.03% |
| Profitability | 0% | 88% | 62% | 92% |
| Total debt ratio | 23.04% | 75.51% | 65.79% | 48.93% |
| Debt ratio change over time | 0% | 0% | 341.77% | 4.46% |
| Dept financing | 8% | 25% | 47% | 17% |
| Current Ratio | 15.8% | 1.87% | 2.93% | 1.99% |
| Quick Ratio | 0% | 1.53% | 2.83% | 1.77% |
| Cash Position Ratio | 14.43% | 0.73% | 2.29% | 0.99% |
| Liquididy | 50% | 31% | 32% | 21% |
| Short-term ratios | CRSP | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -5.06% | 18.05% | 0.63% | 10.52% |
| Return on assets | -5.05% | 3.58% | 3.44% | 6.39% |
| Return on sales | 0% | 36.22% | 35.02% | 46.53% |
| Return on invested capital | -603.25% | 5.97% | 1.16% | 9.33% |
| Profitability | 0% | 74% | 36% | 90% |
| Total debt ratio | 11.62% | 83.77% | 66.41% | 53.87% |
| Debt ratio change over time | 0% | 0% | -1.12% | 4.06% |
| Dept financing | 3% | 25% | 20% | 41% |
| Current Ratio | 15.8% | 1.87% | 2.93% | 1.99% |
| Quick Ratio | 0% | 1.53% | 2.83% | 1.77% |
| Cash Position Ratio | 14.43% | 0.73% | 2.29% | 0.99% |
| Liquididy | 50% | 18% | 34% | 20% |